We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current PBYI market cap is 176.72M. The company's latest EPS is USD 0.4398 and P/E is 8.12.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 56.12M | 72.18M | 43.77M | 47.08M | 80.54M |
| Operating Income | 8.59M | 14.8M | -2.3M | -2.18M | 22.08M |
| Net Income | 5.8M | 12.27M | -4.82M | -4.53M | 20.32M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 272.26M | 225.11M | 253.16M | 228.03M | 235.64M |
| Operating Income | -39.1M | -30.4M | 1.29M | 23.72M | 32.64M |
| Net Income | -75.6M | -60M | -29.13M | 2k | 21.59M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 203.61M | 230.53M | 214.15M | 205M | 220.72M |
| Total Liabilities | 164.86M | 177.09M | 163.17M | 156.49M | 149.63M |
| Total Equity | 38.74M | 53.44M | 50.98M | 48.51M | 71.09M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 234.91M | 244.22M | 226.59M | 222.06M | 230.53M |
| Total Liabilities | 217.44M | 250.17M | 229.03M | 200.45M | 177.09M |
| Total Equity | 17.46M | -5.95M | -2.45M | 21.61M | 53.44M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 16.55M | 27.01M | 11.25M | 12.27M | 23.31M |
| Investing | -10.96M | -19.13M | -19.08M | -18.38M | -18.12M |
| Financing | N/A | N/A | N/A | -11.33M | -22.52M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 22.38M | 773k | 20.65M | -15.83M | 27.01M |
| Investing | 5.16M | 23.4M | -10.88M | 7.1M | -19.13M |
| Financing | -67.07M | 68k | -31.93M | 12.22M | N/A |
| Market Cap | 176.72M |
| Price to Earnings Ratio | 8.12 |
| Price to Sales Ratio | 0.74 |
| Price to Cash Ratio | 2.07 |
| Price to Book Ratio | 3.28 |
| Dividend Yield | - |
| Shares Outstanding | 49.09M |
| Average Volume (1 week) | 448.01k |
| Average Volume (1 Month) | 303.56k |
| 52 Week Change | -44.19% |
| 52 Week High | 7.15 |
| 52 Week Low | 2.225 |
| Spread (Intraday) | 1.14 (30.73%) |
| Company Name | Puma Biotechnology Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.pumabiotechnology.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
